Menu
Recruiting NCT07534956

The Effect of Paedfusor TCI, Eleveld TCI, and Sevoflurane Anesthesia on Postoperative Awakening Agitation in Pediatric Patients

No phase Interventional Emergence Delirium in Pediatric Anesthesia Pediatric Anesthesia Postoperative Agitations in Pediatric Patients Postoperative Nausea and Vomiting (PONV)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: propofol ( Paedfusor Model), propofol (Eleveld Model), Sevofluorane.
Who it may be relevant to
Registry conditions: Emergence Delirium in Pediatric Anesthesia, Pediatric Anesthesia, Postoperative Agitations in Pediatric Patients, Postoperative Nausea and Vomiting (PONV). Basic parameters: 3 years — 10 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Investigation of the Effects of Two Different TCI (Target Controlled Infusion) Models (Paedfusor and Eleveld) and Inhalation Anesthesia on Postoperative Awakening Agitation/Delirium in Pediatric Patients

Overview

Emergence delirium is a common complication in pediatric patients undergoing general anesthesia. The aim of this study is to investigate the incidence of postoperative awakening delirium and agitation in pediatric patients aged 3-10 years (ASA I-II) using two different target-controlled infusion (TCI) methods (Paedfusor and Eleveld) for TIVA, compared to inhalation anesthesia. This study will examine the effect of two different TCI models on postoperative awakening agitation/delirium by comparing them with each other and with inhalation anesthesia.

Detailed description

Postoperative emergence agitation/delirium (POED) is a postoperative complication in pediatric anesthesia and is characterized by perceptual and psychomotor impairment that negatively impacts postoperative recovery. According to the literature, inhalation anesthesia is associated with a higher incidence of ED compared to propofol-based anesthesia. In this study, we aimed to investigate the effect of two different TCI models, in which the depth of general anesthesia was monitored with BIS monitoring, on reducing the incidence of ED.

Both the Paedfusor and Eleveld models describe propofol pharmacokinetics via a three-compartment structure. These pharmacokinetic models are drug infusion models created by taking 600-10,000 blood samples at specific intervals after administering various doses of the drug to real patients and measuring the blood concentrations. They are used to provide a more stable and consistent level of total intravenous anesthesia.

Both models have been used for propofol infusion in pediatric anesthesia for many years. Differences exist between them in terms of distribution volume, elimination rate constant between compartments, and induction and maintenance phases depending on the characteristics of the pharmacokinetic model used. These models are already loaded onto perfusion devices in the operating room. Patient data such as height, weight, and gender are entered into the device, the target dose is determined by the clinician, and the device calculates the necessary dose for induction and maintenance according to the pharmacokinetic models.

This study was designed as a prospective, randomized, controlled, single-blind (evaluator-blind), three-arm clinical trial comparing the effects of total intravenous anesthesia and inhalation anesthesia, administered with two different target-controlled infusion (TCI) models (Paedfusor and Eleveld), on postoperative awakening agitation in pediatric patients aged 3-10 years with ASA I-II status and scheduled for elective urogenital surgery.

Participants will be randomly assigned to one of three groups: Paedfusor TCI, Eleveld TCI, or sevoflurane anesthesia. Standard monitoring and anesthesia protocols will be applied to all patients. Emergence delirium will be assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale, and postoperative pain will be evaluated using the FLACC scale.

Secondary outcomes include severity of emergence delirium, association between bispectral index (BIS)-derived alpha band power and ED, time to emergence, postoperative nausea and vomiting, duration of BIS suppression, and the need for additional sedation and analgesia.

This study aims to provide evidence on the optimal anesthetic approach to reduce emergence delirium in pediatric patients and to explore the neurophysiological correlates of ED using BIS monitoring

Interventions

  • Drug propofol ( Paedfusor Model)
    Propofol will be administered via target-controlled infusion using a Paedfusor model.
  • Drug propofol (Eleveld Model)
    Propofol will be administered via target-controlled infusion using the Eleveld model.
  • Drug Sevofluorane
    Sevoflurane will be administered as an inhalation anesthetic.

Primary outcome measures

  • Emergence Delirium Assessed by PAED Scale [Time frame: Within the first 30 minutes after emergence from anesthesia]
Secondary outcome measures (7)
  • Postoperative Pain Assessed by FLACC Scale [Time frame: Within the first 120 minutes after surgery]
  • Association Between BIS-Derived Alpha Band Power and Emergence Delirium [Time frame: Intraoperative period]
  • Time to Emergence [Time frame: Within the first 120 minutes after surgery]
  • Incidence of Postoperative Nausea and Vomiting [Time frame: Within 30 minutes after the surgery]
  • Duration of BIS Suppression [Time frame: Intraoperative period]
  • Need for Additional Sedation [Time frame: 0-30 minutes postoperatively]
  • Need for Additional Analgesia [Time frame: 0-30 minutes postoperatively]

Eligibility criteria

Inclusion criteria

  • Children aged 3-10 years
  • Children weighing over 10 kg
  • American Society of Anesthesiologists (ASA) physical condition classification I-II
  • Those who will undergo planned urogenital surgery under general anesthesia
  • Those who have obtained written informed consent from their parents or legal guardians

Exclusion criteria

  • Patients assessed as ASA III or higher
  • Known neurological or psychiatric disorders
  • Developmental delay or cognitive impairment
  • Use of sedatives or psychoactive drugs
  • Allergy or contraindication to the study drugs (propofol or sevoflurane)
  • History of previous adverse reactions to anesthesia
  • Patients requiring emergency surgery
  • Significant liver, kidney, or cardiovascular disease
  • Patients whose parents or legal guardians have not given consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 2 centers
  • Marmara University Pendik Research and Training Hospital — Istanbul
  • Marmara University Pendik Research and Training Hospital — Istanbul

Identifiers

NCT: NCT07534956 · 96-01-16-ANES

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗